financetom
Business
financetom
/
Business
/
UBS Previews Next Week's Bank of Canada Policy Decision; Comments on Canadian Dollar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UBS Previews Next Week's Bank of Canada Policy Decision; Comments on Canadian Dollar
May 30, 2025 5:12 AM

07:53 AM EDT, 05/30/2025 (MT Newswires) -- The Bank of Canada is likely to leave its policy rates

unchanged next Wednesday and UBS expects USDCAD to continue its downward trajectory over time.

The bank's opportunity of the week centers around a continuation of the AUDCAD's recent rebound.

The AUDCAD currency pair usually trades in a tight range around the 0.90 level, according to UBS. However, in the aftermath of the "Liberation Day" tariff announcements by United States President Donald Trump, the pair dipped briefly to levels below 0.85 and since then recovered very gradually to 0.89.

In the bank's view, there remains further ground

to make up, with a move above 0.90 likely in the coming

months. Key catalysts include the improving chance of a

U.S.-China trade deal, relative upside for mined commodities versus energy, and a much smoother domestic rebound in Australia.

In addition, UBS doesn't foresee a sharp rally in the

Canadian dollar (CAD or loonie). As a result, the bank likes to be long AUDCAD at 0.89, with a target of 0.92 and a stop-loss of 0.8750.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer wins $10 billion bidding war for Metsera as Novo bows out
Pfizer wins $10 billion bidding war for Metsera as Novo bows out
Nov 8, 2025
(Reuters) -Obesity drug developer Metsera said on Friday that it had accepted Pfizer's $10 billion acquisition offer, ending a fierce bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Pfizer appeared to have locked up the acquisition in September before Novo jumped in last week with an unsolicited offer, sparking a strategic fight for a coveted...
BRIEF-Novo Nordisk Says Will Not Increase Its Proposal To Acquire Metsera, Inc.
BRIEF-Novo Nordisk Says Will Not Increase Its Proposal To Acquire Metsera, Inc.
Nov 8, 2025
Nov 8 (Reuters) - Novo Nordisk A/S: * NOVO NORDISK WILL NOT INCREASE ITS PROPOSAL TO ACQUIRE METSERA, INC. * NOVO NORDISK - WILL NOT INCREASE OFFER FOR METSERA * NOVO NORDISK: BELIEVE THAT STRUCTURE OF OUR POTENTIAL MERGER AGREEMENT IS COMPLIANT WITH ANTITRUST LAWS * NOVO NORDISK: CO WILL NOT INCREASE ITS OFFER TO ACQUIRE METSERA CONSISTENT WITH ITS...
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Nov 7, 2025
Pfizer Inc. ( PFE ) secured a $10 billion deal to acquire obesity drug developer Metsera, Inc. ( MTSR ) , beating out Novo Nordisk ( NVO ) A/S after a heated bidding war that captivated Wall Street. Metsera Board Backs Deal Under the deal, Pfizer ( PFE ) will pay $86.25 per share, consisting of $65.60 in cash and...
UPS grounds its MD-11 fleet after Louisville crash
UPS grounds its MD-11 fleet after Louisville crash
Nov 7, 2025
Nov 7 (Reuters) - UPS on Friday said it has grounded its fleet of McDonnell Douglas MD-11s, the type of plane involved in Tuesday's crash in Louisville, Kentucky, which killed at least 13 people. Out of an abundance of caution and in the interest of safety, we have made the decision to temporarily ground our MD-11 fleet, a UPS spokesperson...
Copyright 2023-2026 - www.financetom.com All Rights Reserved